Urea cycle dysregulation and arginine pathways in the pathogenesis of NAFLD and NASH (Review)
International Journal of Molecular Medicine · 08.06.2026 · 58 (2) · 1-21
DOI: 10.3892/ijmm.2026.5886 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 08.06.2026. Verfasst von Boying Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, Henan 471…. Hauptthemen laut MEDLINE: Arginine, Non-alcoholic Fatty Liver Disease, Urea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Non‑alcoholic fatty liver disease (NAFLD) and its advanced form, non‑alcoholic steatohepatitis (NASH), are now leading causes of chronic liver disease worldwide. Recent evidence highlights the central role of urea cycle and arginine metabolism dysregulation in NAFLD/NASH pathogenesis. Downregulation of key urea cycle enzymes, such as carbamoyl phosphate synthetase 1, ornithine transcarbamylase and argininosuccinate synthase, impairs ammonia detoxification, leading to hyperammonemia, mitochondrial dysfunction and oxidative stress. Epigenetic modifications, notably DNA methylation and histone changes, contribute to this metabolic reprogramming. Aberrant arginine metabolism, particularly the imbalance between urea and nitric oxide (NO) pathways, exacerbates liver inflammation and fibrosis through increased inducible nitric oxide synthase (NOS) activity in macrophages and hepatic stellate cells, driving excessive NO and polyamine production. In contrast, physiological NO signaling via endothelial NOS supports mitochondrial health and metabolic homeostasis. Clinically, urea cycle and arginine metabolites, including blood ammonia and urea cycle metabolites, serve as potential biomarkers for disease severity. Restoring urea cycle function and rebalancing arginine‑NO metabolism through targeted interventions, such as citrulline/arginine supplementation or enzyme modulation, are promising strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
- Department of Interventional Radiology, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
- Department of Endocrinology, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
- Department of Radiation Oncology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
- Department of Gastroenterology, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Zitieren
APA
Zhu, B., Wang, C., Liu, P., Qu, Z., Qi, R., Chen, S., & Niu, H. (2026). Urea cycle dysregulation and arginine pathways in the pathogenesis of NAFLD and NASH (Review). International Journal of Molecular Medicine, 58(2), 1-21. https://doi.org/10.3892/ijmm.2026.5886
Vancouver
Zhu B, Wang C, Liu P, Qu Z, Qi R, Chen S, et al. Urea cycle dysregulation and arginine pathways in the pathogenesis of NAFLD and NASH (Review). International Journal of Molecular Medicine. 2026;58(2):1-21. doi:10.3892/ijmm.2026.5886
BibTeX
@article{Zhu2026,
author = {Zhu, Boying and Wang, Chaoyang and Liu, Peng and Qu, Zhifeng and Qi, Ran and Chen, Shengjiang and Niu, Huanzhang},
title = {Urea cycle dysregulation and arginine pathways in the pathogenesis of NAFLD and NASH (Review)},
journal = {International Journal of Molecular Medicine},
year = {2026},
volume = {58},
number = {2},
pages = {1--21},
doi = {10.3892/ijmm.2026.5886}
}
EUVIMED